Long-term metastatic melanoma survival dramatically improves on immunotherapy, clinical trial finds
Long-term data from a landmark international trial show about half of patients with metastatic melanoma treated with a combination of immune checkpoint inhibitors survive cancer-free for 10 years or more, according to a new ...
Sep 15, 2024
0
111
